Maud de Klerk-Starmans
Title
Cited by
Cited by
Year
Spatial genomic heterogeneity within localized, multifocal prostate cancer
PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ...
Nature genetics 47 (7), 736-745, 2015
3942015
Predicting outcomes in radiation oncology—multifactorial decision support systems
P Lambin, RGPM Van Stiphout, MHW Starmans, E Rios-Velazquez, ...
Nature reviews Clinical oncology 10 (1), 27-40, 2013
3532013
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ...
Nature communications 5 (1), 1-13, 2014
1812014
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ...
Nature communications 5 (1), 1-13, 2014
1812014
How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models
MW van Gisbergen, AM Voets, MHW Starmans, IFM de Coo, R Yadak, ...
Mutation Research/Reviews in Mutation Research 764, 16-30, 2015
1672015
The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung …
P Lambin, SF Petit, HJWL Aerts, WJC van Elmpt, CJG Oberije, ...
Radiotherapy and oncology 96 (2), 145-152, 2010
822010
Impact of supervised gene signatures of early hypoxia on patient survival
R Seigneuric, MHW Starmans, G Fung, B Krishnapuram, DSA Nuyten, ...
Radiotherapy and oncology 83 (3), 374-382, 2007
692007
The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia
MBE Schaaf, D Cojocari, TG Keulers, B Jutten, MH Starmans, MC de Jong, ...
Radiotherapy and Oncology 108 (3), 529-534, 2013
532013
Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types
MHW Starmans, B Krishnapuram, H Steck, H Horlings, DSA Nuyten, ...
British journal of cancer 99 (11), 1884-1890, 2008
512008
Molecular heterogeneity of non‐small cell lung carcinoma patient‐derived xenografts closely reflect their primary tumors
D Wang, NA Pham, J Tong, S Sakashita, G Allo, L Kim, N Yanagawa, ...
International Journal of Cancer 140 (3), 662-673, 2017
482017
The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer
MHW Starmans, KC Chu, S Haider, F Nguyen, R Seigneuric, ...
Radiotherapy and Oncology 102 (3), 436-443, 2012
472012
BPG: Seamless, automated and interactive visualization of scientific data
C P’ng, J Green, LC Chong, D Waggott, SD Prokopec, M Shamsi, ...
BMC bioinformatics 20 (1), 1-5, 2019
452019
A pilot study comparing HPV-positive and HPV-negative head and neck squamous cell carcinomas by whole exome sequencing
AC Nichols, M Chan-Seng-Yue, J Yoo, W Xu, S Dhaliwal, J Basmaji, ...
International Scholarly Research Notices 2012, 2012
452012
Epigenetics in radiotherapy: Where are we heading?
KM Smits, V Melotte, HEC Niessen, L Dubois, C Oberije, EGC Troost, ...
Radiotherapy and Oncology 111 (2), 168-177, 2014
412014
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer
MS Liew, J Sia, MHW Starmans, A Tafreshi, S Harris, M Feigen, S White, ...
Cancer medicine 2 (6), 916-924, 2013
372013
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer
MS Liew, J Sia, MHW Starmans, A Tafreshi, S Harris, M Feigen, S White, ...
Cancer Medicine 2 (6), 916-924, 2013
372013
The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer
T John, MHW Starmans, YT Chen, PA Russell, SA Barnett, SC White, ...
PloS one 8 (7), e67876, 2013
372013
Systematic analysis of 18 F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors
BAW Hoeben, MHW Starmans, RTH Leijenaar, LJ Dubois, ...
BMC cancer 14 (1), 1-12, 2014
252014
Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers
L Dodbiba, J Teichman, A Fleet, H Thai, MHW Starmans, R Navab, ...
PloS one 10 (3), e0121872, 2015
232015
The use of a comprehensive tumour xenograft dataset to validate gene signatures relevant for radiation response
MHW Starmans, D Zips, BG Wouters, M Baumann, P Lambin
Radiotherapy and Oncology 92 (3), 417-422, 2009
232009
The system can't perform the operation now. Try again later.
Articles 1–20